Review found differences in estimated treatments for chlamydia and gonorrhea despite CDC guidelines

Published Date: 02 Mar 2023

A review of chlamydia and gonorrhea prevention studies conducted by the Regenstrief Institute found that rates of presumptive treatment (antibiotics before diagnosis) varied.

Read Full News

Latest News

Ebola Infects More Than 1,000 in Congo, Spreads to Kill Toddler in New Camp

Ebola has now infected more than 1,000 people in the Democratic Republic of Congo in ⁠an outbreak that has spread to a third displacement camp and killed an 18-month-old...

Pfizer's Experimental Drug Misses Main Goal Of Lung Cancer Trial

Pfizer said on Monday that one of the key experimental drugs it picked up in its $43 billion 2023 acquisition of ⁠Seagen failed to improve survival when compared to...

UNAIDS Chief Urges US to Reconsider South Africa Funding Cut

The head of UNAIDS said on Monday she was saddened by U.S. plans to withdraw HIV/AIDS funding for South Africa and urged Washington to reconsider, warning the move could...

UN Agencies Launch $1 Million Project to Contain Screwworm Outbreak

The International Atomic Energy Agency and the U.N. food agency have launched a $1 ⁠million research project to help contain the screwworm outbreak in the Americas,...

Inghams Locks Down Farms After Australia Reports Second H5N1 Case

Inghams Group on Monday implemented a complete lockdown across all of its Western ⁠Australian farms and processing operations after Australia reported a second case of the...

USDA Reports Three New Cases of Screwworm, Bringing Total to 15

The number of U.S. cases of New World screwworm has risen to 15 after three ⁠more animals tested positive in Texas, the Department of Agriculture said in a post on social...

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Ebola has now infected more than 1,000 people in the Democratic Republic of Congo in ⁠an outbreak that has spread to a third displacement camp and killed an 18-month-old...

Pfizer said on Monday that one of the key experimental drugs it picked up in its $43 billion 2023 acquisition of ⁠Seagen failed to improve survival when compared to...

The head of UNAIDS said on Monday she was saddened by U.S. plans to withdraw HIV/AIDS funding for South Africa and urged Washington to reconsider, warning the move could...

The International Atomic Energy Agency and the U.N. food agency have launched a $1 ⁠million research project to help contain the screwworm outbreak in the Americas,...

Inghams Group on Monday implemented a complete lockdown across all of its Western ⁠Australian farms and processing operations after Australia reported a second case of the...

The number of U.S. cases of New World screwworm has risen to 15 after three ⁠more animals tested positive in Texas, the Department of Agriculture said in a post on social...

News All Time

US to Provide $50 Million More in Funding to Counter Ebola Outbreak

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

EMA Curbs Chikungunya Jab After Serious Safety Review

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

Congo Says 782 Ebola Cases Confirmed, Two New Health Zones Affected

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Neurological Effects of Ebola Persist Years After Infection

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

In Congo, Doctors Face Ebola With Little Protection

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

Congo Says Number Of Confirmed Ebola Cases Rises to Nearly 600

The Democratic Republic of Congo on Tuesday said confirmed Ebola cases had climbed to nearly 600, ⁠raising awareness within the local population about the importance of...

US Announces Additional $20 Million for Ebola Response

The U.S. State Department ⁠said on Wednesday it would provide ⁠an additional $20 million to help fight ⁠the Ebola ‌outbreak in Africa, bringing its total direct support to...

US Confirms New Screwworm Cases, as Ranchers Brace for Spread

The U.S. confirmed three additional cases of New World screwworm on Monday, raising the total number of cases to five since the first domestic screwworm infestation in six...

Congo Says Ebola Deaths Top 100 as Armed Groups Threaten Response

Democratic Republic of Congo on Monday said confirmed Ebola deaths had climbed to 101 and that the presence ⁠of armed groups was continuing to hinder the response in the...

Maternal RSV Vaccine Cuts Infant Hospitalization Risk by 68%

Maternal RSV vaccination during pregnancy is associated with protection against RSV-associated acute respiratory illness.

USDA Expects to Contain Screwworm Case in Texas, Rollins Says

U.S. Agriculture Secretary Brooke ⁠Rollins said on Thursday that the USDA believes ⁠it can contain a case of ⁠New World screwworm ‌in Texas, the first case in the state...

PAHO Strengthens Ebola Preparedness

The Pan American Health Organization said on Thursday it is stepping up efforts to help ⁠countries across the Americas to strengthen their preparedness for Ebola.

Recommended News For You

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Examines Office-Based Transperineal Prostate Biopsies Methodology.

Oncology Drug Shortages Persist, but Continue to Evolve

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

Recommended Articles For You

Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors  

Anion Gap: The Simple Calculation That Reveals Much About Your Health  

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond 

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

2.

In cancer survivors, loneliness is associated with a higher risk of death.

3.

How breast tissue density affects your risk of breast cancer

4.

Telemedicine services linked to reducing excess mortality

5.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

1.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

2.

Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances

3.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

4.

Case Study: Personalized Medicine Based on Genetic Profiling in Oncology

5.

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot